Old Web
English
Sign In
Acemap
>
authorDetail
>
Jessica Herrera
Jessica Herrera
Memorial Sloan Kettering Cancer Center
Cancer
Medicine
Internal medicine
Oncology
Clinical endpoint
3
Papers
32
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer
2015
PLOS ONE
Yelena Y. Janjigian
Efsevia Vakiani
Geoffrey Y. Ku
Jessica Herrera
Laura H. Tang
Nancy Bouvier
Agnes Viale
Nicholas D. Socci
Marinela Capanu
Michael F. Berger
David H. Ilson
Show All
Source
Cite
Save
Citations (25)
Can induction chemotherapy improve dysphagia in locally advanced esophageal/GEJ cancer?
2014
Journal of Clinical Oncology
Elizabeth Won
David H. Ilson
Jessica Herrera
Yelena Y. Janjigian
Geoffrey Y. Ku
Nabil P. Rizk
Inderpal S. Sarkaria
Valerie W. Rusch
Prasad S. Adusumili
Manjit S. Bains
Show All
Source
Cite
Save
Citations (1)
Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response and prolonged stable disease observed in adenocarcinoma.
2011
Journal of Clinical Oncology
Geoffrey Y. Ku
Yelena Y. Janjigian
Manish A. Shah
Jessica Herrera
Laura H. Tang
Louis Fuqua
Marinela Capanu
David H. Ilson
Show All
Source
Cite
Save
Citations (6)
1